La cadena de opciones muestra datos clave de las opciones de acciones de Tempest Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Tempest Therapeutics..

Tempest Therapeutics (NASDAQ:TPST) Bolsa, Cadena de Opciones

TEMPEST THERAPEUTICS INC

Tempest Therapeutics

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics Inc

Earnings

Press Releases

Tempest Reports Year End 2024 Financial Results and  Provides Business Update

Health Care

General

Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value

Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP

News

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

Tempest Reports First Quarter 2025 Financial Results and Provides Business Update

Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

Opinion

After Major Oncology Conference, All Eyes Turn to Industry Innovation

Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

CTOR

CTXR

ONCY

TPST

TSX:ONC

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Annovis Bio

AlphaTON Capital

BioAtla

Dyadic International, Inc. - Common Stock

Dyadic International

Elutia

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

Generation Bio

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

LAVA Therapeutics

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

Pluri

Plus Therapeutics

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Lunai Bioworks

RenovoRx

Senti Biosciences

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Xilio Therapeutics

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

XOMA Royalty

8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th

Comments

Tempest Therapeutics

Tempest Therapeutics (TPST) Opciones

Tempest Therapeutics (NASDAQ:TPST) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL